Security key
09061G101
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)
CUSIP: 09061G101
Q1 2020 13F Holders as of 31 Mar 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 192,632,743
- Total 13F shares
- 176,765,627
- Share change
- +3,391,896
- Total reported value
- $14,935,321,561
- Put/Call ratio
- 74%
- Price per share
- $84.50
- Number of holders
- 489
- Value change
- +$286,486,516
- Number of buys
- 252
- Number of sells
- 202
Report period
Q1 2020
Institutions
489
Top holders
10
BMRN full security history
Newer quarter: Q2 2020
Previous quarter: Q4 2019
BIOMARIN PHARMACEUTICAL INC SEC filings
BIOMARIN PHARMACEUTICAL INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09061G101
Recent filing periods:
Top shareholders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital Research Global Investors |
13F
|
Company |
11%
|
22,004,065
|
$1,860,444,000 | — | 31 Dec 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.6%
|
16,536,780
|
$1,398,185,000 | — | 31 Dec 2019 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
8.5%
|
16,329,320
|
$1,380,644,000 | — | 31 Dec 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.8%
|
13,057,981
|
$1,104,054,000 | — | 31 Dec 2019 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
3.9%
|
7,589,294
|
$641,675,000 | — | 31 Dec 2019 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
3.7%
|
7,040,173
|
$595,247,000 | — | 31 Dec 2019 | |
| Clearbridge Investments, LLC |
13F
|
Company |
3.2%
|
6,198,466
|
$520,919,000 | — | 31 Dec 2019 | |
| STATE STREET CORP |
13F
|
Company |
2.5%
|
4,911,315
|
$415,252,000 | — | 31 Dec 2019 | |
| DODGE & COX |
13F
|
Company |
2.3%
|
4,389,515
|
$371,133,000 | — | 31 Dec 2019 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.7%
|
3,196,859
|
$270,258,000 | — | 31 Dec 2019 | |
| Capital International Investors |
13F
|
Company |
1.3%
|
2,567,237
|
$217,060,000 | — | 31 Dec 2019 | |
| Capital World Investors |
13F
|
Company |
1.3%
|
2,493,178
|
$210,798,000 | — | 31 Dec 2019 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
1.2%
|
2,372,712
|
$200,613,000 | — | 31 Dec 2019 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.1%
|
2,116,054
|
$178,912,000 | — | 31 Dec 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.1%
|
2,040,153
|
$172,495,000 | — | 31 Dec 2019 | |
| Palo Alto Investors LP |
13F
|
Company |
1%
|
2,021,136
|
$170,887,000 | — | 31 Dec 2019 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
1%
|
2,000,000
|
$169,100,000 | — | 31 Dec 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
1,935,812
|
$163,516,000 | — | 31 Dec 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.96%
|
1,841,942
|
$155,735,000 | — | 31 Dec 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.91%
|
1,753,688
|
$148,275,000 | — | 31 Dec 2019 | |
| NORGES BANK |
13F
|
Company |
0.91%
|
1,752,841
|
$148,203,000 | — | 31 Dec 2019 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
0.84%
|
1,621,739
|
$137,118,000 | — | 31 Dec 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.84%
|
1,612,717
|
$136,355,000 | — | 31 Dec 2019 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.7%
|
1,347,160
|
$113,902,378 | — | 31 Dec 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.68%
|
1,301,177
|
$110,008,000 | — | 31 Dec 2019 | |
| USS Investment Management Ltd |
13F
|
Company |
0.61%
|
1,178,462
|
$99,633,000 | — | 31 Dec 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.59%
|
1,138,859
|
$96,290,000 | — | 31 Dec 2019 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.57%
|
1,107,561
|
$93,644,000 | — | 31 Dec 2019 | |
| Manning & Napier Group, LLC |
13F
|
Company |
0.57%
|
1,100,191
|
$93,020,000 | — | 31 Dec 2019 | |
| Legal & General Group Plc |
13F
|
Company |
0.52%
|
997,128
|
$84,308,000 | — | 31 Dec 2019 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.5%
|
955,275
|
$80,769,000 | — | 31 Dec 2019 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.45%
|
866,091
|
$73,228,000 | — | 31 Dec 2019 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.45%
|
858,080
|
$72,550,000 | — | 31 Dec 2019 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.39%
|
759,861
|
$64,246,000 | — | 31 Dec 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.39%
|
742,924
|
$62,814,000 | — | 31 Dec 2019 | |
| TCW GROUP INC |
13F
|
Company |
0.38%
|
740,844
|
$62,638,000 | — | 31 Dec 2019 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.36%
|
697,434
|
$58,968,000 | — | 31 Dec 2019 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.35%
|
682,921
|
$57,741,000 | — | 31 Dec 2019 | |
| SAMLYN CAPITAL, LLC |
13F
|
Company |
0.35%
|
675,370
|
$57,103,000 | — | 31 Dec 2019 | |
| FMR LLC |
13F
|
Company |
0.33%
|
635,253
|
$53,711,000 | — | 31 Dec 2019 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.32%
|
624,417
|
$52,794,000 | — | 31 Dec 2019 | |
| Invesco Ltd. |
13F
|
Company |
0.32%
|
619,303
|
$52,363,000 | — | 31 Dec 2019 | |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC |
13F
|
Company |
0.32%
|
614,710
|
$51,974,000 | — | 31 Dec 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.32%
|
609,815
|
$51,560,000 | — | 31 Dec 2019 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.31%
|
595,814
|
$50,376,000 | — | 31 Dec 2019 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.3%
|
580,101
|
$49,047,000 | — | 31 Dec 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.3%
|
575,570
|
$48,665,000 | — | 31 Dec 2019 | |
| AMUNDI ASSET MANAGEMENT US, INC. |
13F
|
Company |
0.3%
|
569,970
|
$48,190,000 | — | 31 Dec 2019 | |
| Swiss National Bank |
13F
|
Company |
0.29%
|
565,932
|
$47,850,000 | — | 31 Dec 2019 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.29%
|
553,634
|
$46,810,000 | — | 31 Dec 2019 |
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q1 2020
As of 31 Mar 2020,
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by
489 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
176,765,627 shares.
The largest 10 holders included
Capital Research Global Investors, PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, BlackRock Inc., JENNISON ASSOCIATES LLC, BAKER BROS. ADVISORS LP, Clearbridge Investments, LLC, STATE STREET CORP, Dodge & Cox, and AMERIPRISE FINANCIAL INC.
This page lists
490
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2020 vs Q4 2019 Across Filers
Q4 2019 holders
454
Q1 2020 holders
489
Holder diff
35
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 Value $ | Q1 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.